EMEA-000880-PIP02-11-M04

Key facts

Active substance
sonidegib
Therapeutic area
Oncology
Decision number
P/0111/2020
PIP number
EMEA-000880-PIP02-11-M04
Pharmaceutical form(s)
  • Capsule, hard
  • Film-coated tablet
  • Powder and solvent for oral suspension
Condition(s) / indication(s)
Treatment of medulloblastoma
Route(s) of administration
Oral use
Contact for public enquiries
Sun Pharmaceutical Industries Europe B.V.

E-mail: juliette.omtzigt@sunpharma.com
Tel.  +31 233034307

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating